Patients, doctors hail 'revolutionary' new drug for pancreatic cancer (opens in new tab)

The FDA recently gave some patients early access to the drug, daraxonrasib, as it nears regulatory approval. It's the first treatment to considerably extend the lives of people with pancreatic cancer.